$232.08
▲ +0.1% Today
as of Jul 22, 16:48 ET
Last 30 days
Recent Press Releases & News
DVA: Raising target price to $249.00
DaVita Inc. Schedules 2nd Quarter 2026 Investor Conference Call
DaVita HealthCare (DVA) Advances While Market Declines: Some Information for Investors
Overview
52-week range
$101
$203
100% of range
Avg surprise (last 3)
+14.2%
Avg reaction (last 2)
+1.2%
100% positive
Latest IV / EM
53%
EM ±12.1% · $230 · Aug 21
Earnings trends
EPS — actual vs estimate
Actual Estimate
Revenue vs Net Income
Revenue Net income
Earnings history
| Date | Period | Actual EPS | Est | Surprise | YoY %Δ | Day react | Source |
|---|---|---|---|---|---|---|---|
| Tue May 5, 2026 | Mar/2026 | $2.87 | $2.41 | +19.1% | +43.5% | +1.9% | earnings |
| Tue Sep 30, 2025 | Sep 2025 | $2.04 | — | — | — | — | financials |
| Tue Aug 5, 2025 | Jun/2025 | $2.95 | $2.70 | +9.3% | — | — | earnings |
| Mon May 12, 2025 | Mar/2025 | $2.00 | $1.75 | +14.3% | — | +0.5% | earnings |
| Mon Sep 30, 2024 | Sep 2024 | $2.50 | — | — | — | — | financials |
| Sun Jun 30, 2024 | Jun 2024 | $2.50 | — | — | — | — | financials |
| Sun Mar 31, 2024 | Mar 2024 | $2.65 | — | — | — | — | financials |
| Sat Sep 30, 2023 | Sep 2023 | $2.62 | — | — | — | — | financials |
| Fri Jun 30, 2023 | Jun 2023 | $1.91 | — | — | — | — | financials |
Upcoming
| Date | Fiscal | Time | EPS Est | LY EPS | YoY %Δ |
|---|---|---|---|---|---|
| Tue Aug 4, 2026 | Jun/2026 | OTHER | $4.01 | $2.95 | +35.9% |
Financials
Income statement (quarterly)
| Metric | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $3.42B | — | $3.42B | $3.38B | $3.22B | — | $3.26B | $3.19B |
| Cost of revenue | — | — | — | — | — | — | — | — |
| Gross profit | — | — | — | — | — | — | — | — |
| Operating income | $482M | — | $506M | $538M | $439M | — | $535M | $506M |
| Net income | $198M | — | $150M | $199M | $163M | — | $215M | $223M |
| EPS (diluted) | $2.87 | — | $2.04 | $2.58 | $2.00 | — | $2.50 | $2.50 |
Balance sheet (quarterly)
| Metric | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $644M | $676M | $706M | $708M | $439M | $795M | $1.07B | $416M |
| Inventory | $142M | $161M | $139M | $146M | $151M | $135M | $129M | $127M |
| Total current assets | $4.06B | $4.06B | $4.11B | $4.09B | $3.64B | $3.75B | $4.04B | $3.47B |
| Total assets | $17.50B | $17.48B | $17.56B | $17.49B | $17.12B | $17.29B | $17.50B | $17.03B |
| Long-term debt | — | — | — | — | — | — | — | — |
| Total liabilities | $16.45B | $16.32B | $16.22B | $15.94B | $15.46B | $15.19B | $15.28B | $14.60B |
| Total equity | $-755M | $-651M | $-572M | $-370M | $-267M | $121M | $387M | $633M |